222 related articles for article (PubMed ID: 31627351)
1. Ultrasonographic Evaluation of Fatty Pancreas in Serbian Patients with Non Alcoholic Fatty Liver Disease-A Cross Sectional Study.
Milovanovic T; Dragasevic S; Stojkovic Lalosevic M; Zgradic S; Milicic B; Dumic I; Kmezic S; Saponjski D; Antic A; Markovic V; Popovic D
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31627351
[No Abstract] [Full Text] [Related]
2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
3. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.
Li S; Su L; Lv G; Zhao W; Chen J
Medicine (Baltimore); 2017 Sep; 96(37):e8060. PubMed ID: 28906401
[TBL] [Abstract][Full Text] [Related]
4. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
5. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.
Patel NS; Peterson MR; Brenner DA; Heba E; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2013 Mar; 37(6):630-9. PubMed ID: 23383649
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Clinical and Histopathologic Parameters with Ultrasonographic Grades in Pediatric Non-Alcoholic Fatty Liver Disease.
Kang BK; Kim M; Shin SJ; Kim YJ
J Korean Med Sci; 2019 Dec; 34(47):e298. PubMed ID: 31808322
[TBL] [Abstract][Full Text] [Related]
10. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
11. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease.
Salmanroghani H; Salmanroghani R; Nourian M; Khayarn K; Lahmi F; Iravani S
Turk J Gastroenterol; 2019 Feb; 30(2):163-170. PubMed ID: 30541716
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
Nasr P; Hilliges A; Thorelius L; Kechagias S; Ekstedt M
Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and clinical implications of pancreatic fat accumulation identified during a medical check-up.
Okada K; Watahiki T; Horie K; Takayama T; Aida Y; To K; Shida T; Ishige K; Nishiyama H; Shoda J; Suzuki H
Medicine (Baltimore); 2021 Oct; 100(41):e27487. PubMed ID: 34731128
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
Cho KI; Jo EA; Cho SH; Kim BH
Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
[TBL] [Abstract][Full Text] [Related]
16. Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker.
Okasha HH; Hegazy MA; Shaker O; Elfatah YA; El-Sawy SS; Abdelfatah D; Abdellatef A
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102364. PubMed ID: 38788255
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
Rosenblatt R; Mehta A; Snell D; Hissong E; Kierans AS; Kumar S
Dig Dis Sci; 2019 Jan; 64(1):262-268. PubMed ID: 30269271
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
20. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
